A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

NCT00147485 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class

Stopped See Detailed Description

Conditions

Interventions

Sponsor

Pfizer